The pharmaceutical industry is entering a critical era where temperature-controlled storage—spanning both Controlled Room Temperature (CRT: 15–25°C) and refrigerated (2–8°C) environments—plays a pivotal role in product integrity, patient safety, and supply chain efficiency. As demand surges for biologics, vaccines, and specialized treatments, reliable temperature-controlled logistics has become not just a necessity but a strategic asset.
Looking Back: The Evolution of Temperature-Sensitive Storage
From 2020 through 2022, the COVID-19 pandemic reshaped global supply chains and thrust cold-chain logistics into the spotlight. The distribution of mRNA-based vaccines—many of which required ultra-cold or refrigerated storage—challenged existing infrastructure and underscored the need for flexible, scalable temperature management. Even as vaccine production has stabilized, the demand for both CRT and refrigerated (2–8°C) storage remains high.
Today, many of the most in-demand therapies—including seasonal flu vaccines, cell and gene therapies, and obesity treatments like Wegovy (Novo Nordisk) and Mounjaro (Eli Lilly)—must be stored between 2–8°C. This range has become the standard requirement for most finished pharmaceutical products, setting a new bar for storage capabilities across the industry.
Key Drivers of Temperature-Controlled Storage Demand
A variety of forces are shaping the growing need for robust CRT and refrigerated storage:
- Biologics & Personalized Medicine
These advanced therapies are highly sensitive to temperature variation. While some require CRT conditions, many must be stored at 2–8°C to maintain efficacy—especially through distribution and last-mile delivery. - Vaccines
Seasonal and emerging infectious disease vaccines continue to rely on cold-chain systems, with most finished products requiring refrigeration to ensure safety and potency. - Specialty and Rare Disease Treatments
Oncology drugs, autoimmune therapies, and other high-value treatments often fall within the 2–8°C range due to their sensitivity and complexity. - Obesity Medications
The global rise in obesity, along with the success of GLP-1 receptor agonists, is driving explosive growth in refrigerated drug volumes.
Together, these trends are transforming not only what we store—but how we store it.
Storage Forecast: 2025–2035
The coming decade is expected to bring rapid growth across all categories of temperature-controlled storage—but refrigerated (2–8°C) volumes are projected to expand the fastest.
- Biologics: 6% CAGR through 2035
- Vaccines: 5% CAGR
- Obesity Medications: Volume expected to triple by 2030
While CRT (15–25°C) storage will continue to be essential, refrigerated storage is forecasted to account for the majority of growth, especially in finished goods storage. By 2030, storage utilization across both CRT and 2–8°C is projected to exceed 90%, with refrigeration-specific shortages leading to storage price increases of up to 25%.
Meeting the Moment: Industry Response
The temperature-controlled logistics industry is responding with a combination of technological advancement and operational expansion:
- Automation & Robotics
Facilities are integrating automated storage systems, robotic palletizers, and smart sensors to streamline operations and reduce human error—particularly critical in 2–8°C environments. - Sustainable Solutions
As energy usage becomes a top concern, newer facilities are adopting energy-efficient refrigeration technologies to meet both operational goals and ESG standards. - Blockchain & Data Transparency
Real-time temperature tracking and blockchain verification are improving traceability, regulatory compliance, and quality control throughout the supply chain.
These innovations will be especially vital as demand intensifies for high-volume, high-value products requiring strict temperature control.
Preparing for the Future
The next 10 years will challenge pharmaceutical logistics in new ways, with 2–8°C refrigerated storage leading the charge. Companies that invest early in scalable, compliant cold-chain infrastructure will be better positioned to ensure product availability, maintain quality, and stay ahead of regulatory demands.
At Langham Logistics, we understand the complexity of temperature-controlled pharmaceutical storage. From CRT to refrigerated 2–8°C solutions, our facilities and processes are designed to support safe, reliable, and scalable pharmaceutical distribution.
Need support for your temperature-sensitive pharmaceutical products?
Connect with Langham Logistics today to learn how we can help you stay prepared for what’s next.
Ready to learn more? Contact Langham Logistics to discover how we can help you achieve reliable and efficient controlled room temperature storage.
